Page 29 - Sohini Das

After launch of Bajaj Freedom 125, TVS may roll out its own CNG bike

The CNG fuel option in the commuter segment offers a reduced fuel bill for the consumer

Honda two-wheeler share increases after on-board norms compliance

Sales gap with Hero narrows to 45,000 units in June

Sun Pharma open to exploring acquisitions in global specialty portfolio

Sun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipeline

Mercedes looks to charge up India play, posts 60% rise in battery EV sales

The company launched the EQA 250+ on Monday, priced at Rs 66 lakh, which comes with a range of 497-560 km per charge

Bajaj Auto strikes 'Tiger Zinda Hai' note as first CNG bike hits the road

Bajaj Auto launches world's first CNG-powered bike Freedom 125 at Rs 95k

Bajaj Auto set to launch world's first CNG bike 'Freedom 125' on Friday

The bike is likely to have flexible fuel options and will feature two separate switches for petrol and CNG

India's medical tourism gets booster shot from Bangladesh visitors

During the general elections, however, there has been a temporary lull in patients from Bangladesh as well as less visas were issued

The tweet that built Bujji, Jayem Auto's 6-tonne beast for Kalki 2898 AD

The concept of this car which has three large wheels and runs on an electric propulsion system powered by a 47 kWh battery pack started about two years back

Mumbai-based Wockhardt to launch its novel antibiotic Zaynich by FY25-end

Global launch in FY26 after multinational clinical trial ends

Emcure Pharma seeks to raise Rs 1,952 cr through IPO, issue opens July 3

Fourth largest IPO of 2024; company will use the proceeds to repay debt and for general corporate purposes

India to make Ozempic-like drugs for diabetes, obesity under PLI by 2026

GLP-1RA works by activating GLP-1 receptors in the pancreas, which leads to enhanced insulin release and reduced glucagon release responses

CDSCO cracks whip on drug manufacturing units over quality lapses

Shuts down 36% of facilities for failing to meet quality standards

40% investment by TaMo CV arm in FY25 to be in advanced tech: Girish Wagh

"We will continue to invest in software," Wagh said, adding capex in the CV business would be around 2-4 per cent of revenues

CAFE III emission targets to disrupt PV market trends 2027 onwards: Chandra

Shailesh Chandra, managing director, Tata Motors Passenger Vehicles and Tata Passenger Electric Mobility, said that CAFE III standards, which will hit the industry around 2027

Demerger will help secure synergies in EVs, autonomous vehicles: TaMo chief

PV business will invest in vehicle platforms, products; CV business will focus on spares, smart mobility solutions to reduce the volatility of vehicle sales

Sun Pharma completes Taro merger, acquires all outstanding shares

New York headquartered Taro has operations in the US, Canada, Israel, and Japan with manufacturing facilities in Canada (Brampton) and Israel (Haifa)

Bharat Bio moves to include ICMR as co-owner in patent filings for Covaxin

As firm corrects 'inadvertent' mistake, experts feel it's not uncommon to add new parties to patent filings

Imports of bulk drugs grew by 13.06% in April-May as prices cooled

Industry insiders say pharma players are taking advantage and stocking up on APIs

Meril launches indigenously developed knee-replacement robotic system

The company claimed that at Rs 2 crore, MISSO is priced around 66 per cent lower than the available robotic knee replacement systems in the Indian market

Emcure Pharmaceuticals gets market regulator Sebi's approval for IPO

IPO comprises fresh issue of equity shares worth Rs 800 crore and OFS of 13.6 million equity shares by promoters